Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $1.1 million.

  • Zenas BioPharma's Non Operating Income fell 5454.16% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 10001.81%. This contributed to the annual value of $8.2 million for FY2024, which is 121009.62% up from last year.
  • As of Q3 2025, Zenas BioPharma's Non Operating Income stood at $1.1 million, which was down 5454.16% from $3.0 million recorded in Q2 2025.
  • Zenas BioPharma's Non Operating Income's 5-year high stood at $3.6 million during Q1 2025, with a 5-year trough of -$16000.0 in Q3 2023.
  • Moreover, its 3-year median value for Non Operating Income was $1.9 million (2024), whereas its average is $1.8 million.
  • Per our database at Business Quant, Zenas BioPharma's Non Operating Income skyrocketed by 1496250.0% in 2024 and then crashed by 5454.16% in 2025.
  • Quarter analysis of 3 years shows Zenas BioPharma's Non Operating Income stood at $793000.0 in 2023, then skyrocketed by 334.8% to $3.4 million in 2024, then crashed by 68.65% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $3.0 million for Q2 2025, and $3.6 million during Q1 2025.